ストックスクリーナーアプリを入手
0.9551
6.36%
-0.0649
前日終値:
$1.02
開ける：
$1.02
24時間の取引高:
169.58K
Relative Volume:
0.45
時価総額：
$5.56M
収益：
-
当期純損益:
$-23.42M
株価収益率:
-0.0122
EPS:
-78
ネットキャッシュフロー:
$-16.67M
1週間 パフォーマンス:
-7.27%
1か月 パフォーマンス:
-27.09%
6か月 パフォーマンス:
-89.21%
1年 パフォーマンス:
-95.96%
1日の値動き範囲:
$0.9522
$1.0254
1週間の範囲:
$0.9522
$1.0999
52週間の値動き範囲:
$0.9522
$31.00
Mustang Bio Inc Stock (MBIO) Company Profile
MBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.9551 | 5.56M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.20 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
525.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.09 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
551.22 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
242.07 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-18 | 開始されました | BTIG Research | Buy |
| 2020-10-02 | 開始されました | B. Riley FBR | Buy |
| 2019-11-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-08-13 | 開始されました | H.C. Wainwright | Buy |
| 2019-06-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Mustang Bio Inc (MBIO) 最新ニュース
Mustang Bio (NASDAQ:MBIO) Shares Down 5.1% – What’s Next? - Defense World
ASCO: Kite’s Glioblastoma CAR-T Highlights Solid Tumor Progress - insights.citeline.com
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
CAR T Cell Therapy Market Projected to Witness Massive Growth - openPR.com
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
Mustang Bio Reports Improved Financials Amid Strategic Adjustments - TipRanks
Mustang Bio (NASDAQ:MBIO) Rating Increased to Hold at Wall Street Zen - Defense World
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Asia-Pacific Personalized Cell Therapy Market Report - openPR.com
Arvinas (NASDAQ:ARVN) and Mustang Bio (NASDAQ:MBIO) Financial Contrast - Defense World
Geode Capital Management LLC Purchases 38,951 Shares of Mustang Bio, Inc. (NASDAQ:MBIO) - Defense World
Cell Therapy Market Growth Set to Surge Significantly during 2025 – 2032 - newstrail.com
Closing Bell Recap: Mustang Bio Inc (MBIO) Ends at 1.22, Reflecting a -1.61 Downturn - DWinneX
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - MSN
Mustang Bio stock plunges to 52-week low of $1.12 - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.12 By Investing.com - Investing.com South Africa
Financial Analysis: Bio-Key International Inc (BKYI)’s Ratios Unveil Key Insights - DWinneX
Cell Therapy Market Future Path and Key Opportunities 2025 – 2032 - newstrail.com
Mustang Bio (MBIO) Sells Facility to AbbVie for $1 Million - GuruFocus
Mustang Bio Inc: Rising -98.18% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com
Mustang Bio (MBIO) Regains Nasdaq Compliance - GuruFocus
Now Is The Time To Build A Position In Mustang Bio Inc (NASDAQ:MBIO) - Marketing Sentinel
What to expect from MBIO’s earnings report this quarter? - uspostnews.com
Mustang Bio stock hits 52-week low at $1.20 amid sharp decline - Investing.com Canada
Mustang Bio stock hits 52-week low at $1.20 amid sharp decline By Investing.com - Investing.com South Africa
Fortress Biotech Inc. (FBIO) reports earnings - Quartz
Mustang Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Mustang Bio Inc. (MBIO) reports earnings - Quartz
MUSTANG BIO, INC. SEC 10-K Report - TradingView
Mustang Bio stock plunges to 52-week low of $1.35 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.35 - Investing.com India
Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com
Car T Cell Therapy Market Demand, Statistics, Future Growth and Outlook 2025-2032 | Mustang Bio, Fate Therapeutics - openPR
Mustang Bio stock plunges to 52-week low of $1.43 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.43 - Investing.com India
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Petri Dish: Biotech leaves Worcester; Novo Nordisk, Eli Lilly partnerships - The Business Journals
Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements - Nasdaq
Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com Canada
Mustang Bio meets Nasdaq’s equity listing requirements - Investing.com India
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times
Mustang Bio, Inc. Regains Compliance with Nasdaq Capital Market Listing Requirements - Nasdaq
Mustang Bio Overcomes Delisting Threat: What This Nasdaq Compliance Means for Investors - StockTitan
Mustang Bio Inc (MBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
0.23%
大文字化:
|
ボリューム (24 時間):